These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 27417698)
21. Diosgenin Prevents Microglial Activation and Protects Dopaminergic Neurons from Lipopolysaccharide-Induced Neural Damage In Vitro and In Vivo. Lee SL; Tu SC; Hsu MY; Chin TY Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638697 [TBL] [Abstract][Full Text] [Related]
22. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis. Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D Front Immunol; 2018; 9():2527. PubMed ID: 30455692 [TBL] [Abstract][Full Text] [Related]
23. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models. Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone. Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180 [TBL] [Abstract][Full Text] [Related]
26. Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease. Bao LH; Zhang YN; Zhang JN; Gu L; Yang HM; Huang YY; Xia N; Zhang H J Neuroinflammation; 2018 May; 15(1):131. PubMed ID: 29720230 [TBL] [Abstract][Full Text] [Related]
27. Biochanin A protects against focal cerebral ischemia/reperfusion in rats via inhibition of p38-mediated inflammatory responses. Wang W; Tang L; Li Y; Wang Y J Neurol Sci; 2015 Jan; 348(1-2):121-5. PubMed ID: 25466482 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 receptor antagonist reduces neonatal lipopolysaccharide-induced long-lasting neurobehavioral deficits and dopaminergic neuronal injury in adult rats. Pang Y; Tien LT; Zhu H; Shen J; Wright CF; Jones TK; Mamoon SA; Bhatt AJ; Cai Z; Fan LW Int J Mol Sci; 2015 Apr; 16(4):8635-54. PubMed ID: 25898410 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models. Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477 [TBL] [Abstract][Full Text] [Related]
30. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo. Bok E; Chung YC; Kim KS; Baik HH; Shin WH; Jin BK Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 29968707 [TBL] [Abstract][Full Text] [Related]
31. Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide. Beier EE; Neal M; Alam G; Edler M; Wu LJ; Richardson JR Neurobiol Dis; 2017 Dec; 108():115-127. PubMed ID: 28823928 [TBL] [Abstract][Full Text] [Related]
32. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration. Neal ML; Fleming SM; Budge KM; Boyle AM; Kim C; Alam G; Beier EE; Wu LJ; Richardson JR FASEB J; 2020 Jan; 34(1):1679-1694. PubMed ID: 31914683 [TBL] [Abstract][Full Text] [Related]
34. Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease. Jang H; Kim S; Lee JM; Oh YS; Park SM; Kim SR Neuroreport; 2017 Mar; 28(5):242-249. PubMed ID: 28178069 [TBL] [Abstract][Full Text] [Related]
35. Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation. Chen C; Wei YZ; He XM; Li DD; Wang GQ; Li JJ; Zhang F Front Immunol; 2019; 10():936. PubMed ID: 31118933 [No Abstract] [Full Text] [Related]
36. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model. Qiu X; Wang Q; Hou L; Zhang C; Wang Q; Zhao X Toxicol Lett; 2021 Oct; 349():1-11. PubMed ID: 34052309 [TBL] [Abstract][Full Text] [Related]
37. Tangeretin exerts anti-neuroinflammatory effects via NF-κB modulation in lipopolysaccharide-stimulated microglial cells. Shu Z; Yang B; Zhao H; Xu B; Jiao W; Wang Q; Wang Z; Kuang H Int Immunopharmacol; 2014 Apr; 19(2):275-82. PubMed ID: 24462494 [TBL] [Abstract][Full Text] [Related]
38. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase. Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631 [TBL] [Abstract][Full Text] [Related]
39. Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation. Hu X; Zhou H; Zhang D; Yang S; Qian L; Wu HM; Chen PS; Wilson B; Gao HM; Lu RB; Hong JS J Neuroimmune Pharmacol; 2012 Mar; 7(1):187-201. PubMed ID: 21870076 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model. He Q; Li YH; Guo SS; Wang Y; Lin W; Zhang Q; Wang J; Ma CG; Xiao BG Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]